These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 30550846)
1. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis. Uddin R; Masood F; Azam SS; Wadood A Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846 [TBL] [Abstract][Full Text] [Related]
2. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB. Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799 [TBL] [Abstract][Full Text] [Related]
3. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii. Ahmad S; Raza S; Uddin R; Azam SS J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis. Kaur H; Kalia M; Taneja N Microb Pathog; 2021 Mar; 152():104608. PubMed ID: 33166618 [TBL] [Abstract][Full Text] [Related]
5. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799 [TBL] [Abstract][Full Text] [Related]
6. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery. Ahmad S; Ranaghan KE; Azam SS Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936 [TBL] [Abstract][Full Text] [Related]
7. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates. Samal HB; Prava J; Suar M; Mahapatra RK J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765 [TBL] [Abstract][Full Text] [Related]
8. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays. Skariyachan S; Manjunath M; Bachappanavar N J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934 [TBL] [Abstract][Full Text] [Related]
10. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis. Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184 [TBL] [Abstract][Full Text] [Related]
11. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. Hassan A; Naz A; Obaid A; Paracha RZ; Naz K; Awan FM; Muhmmad SA; Janjua HA; Ahmad J; Ali A BMC Genomics; 2016 Sep; 17(1):732. PubMed ID: 27634541 [TBL] [Abstract][Full Text] [Related]
12. Vaccinomics to Design a Multi-Epitopes Vaccine for Ud-Din M; Albutti A; Ullah A; Ismail S; Ahmad S; Naz A; Khurram M; Haq MU; Afsheen Z; Bakri YE; Salman M; Shaker B; Tahir Ul Qamar M Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564967 [TBL] [Abstract][Full Text] [Related]
13. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii. Verma P; Tiwari M; Tiwari V J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677 [TBL] [Abstract][Full Text] [Related]
14. Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates. Butt AM; Nasrullah I; Tahir S; Tong Y PLoS One; 2012; 7(8):e43080. PubMed ID: 22912793 [TBL] [Abstract][Full Text] [Related]
15. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii. Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808 [TBL] [Abstract][Full Text] [Related]
16. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Kim HU; Kim TY; Lee SY Mol Biosyst; 2010 Feb; 6(2):339-48. PubMed ID: 20094653 [TBL] [Abstract][Full Text] [Related]
17. Promising Tan YC; Lahiri C Front Immunol; 2022; 13():900509. PubMed ID: 35720310 [TBL] [Abstract][Full Text] [Related]
18. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528 [TBL] [Abstract][Full Text] [Related]
20. Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry. Lin CH; Su SC; Ho KH; Hsu YW; Lee KR Int J Antimicrob Agents; 2014 Jul; 44(1):38-46. PubMed ID: 24837410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]